Atypical teratoid/rhabdoid tumor of the central nervous system in infancy and childhood was established as an entity based on histological, immunohistochemical, and cytogenetic studies. We report the case of a 7-month-old girl who presented with progressive paraplegia and hypesthesia of her legs. Imaging studies revealed a spinal cord mass occupying the entire spinal canal below the T7 level. Through a T12-L3 laminectomy, the intramedullary tumor was partially debulked. Histologically, the tumor specimen had rhabdoid cells, and immunostaining showed vimentin and cytokeratin positivity. No abnormality of chromosome 22q was detected with the fluorescence in situ hybridization method.

Keywords:
Atypical teratoid/rhabdoid tumor, Chromosome 22, Spinal cord tumors
1.
Bhattacharjee M, Hicks J, Langford L, Dauser R, Strother D, Chintagumpala M, Horowits M, Cooley L, Vogel H: Central nervous system atypical teratoid/rhabdoid tumor of infancy and childhood. Ultrastruct Pathol 1997;21:369–378.
2.
Biegel JA, Zhou J-Y, Rorke LB, Stenstrom C, Wainwright LM, Fogelgren B: Germ-line and acquired mutations of INI1 in atpyical teratoid and rhabdoid tumors. Cancer Res 1999;59:74–79.
3.
Burger PC, Yu IT, Tihan T, Friedman HS, Strother DR, Kepner JL, Duffner PK, Kun LE, Perlman EJ: Atpyical teratoid/rhabdoid tumor of the central nervous system: A highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: A Pediatric Oncology Group study. Am J Surg Pathol 1998;22:1083–1092.
4.
Hilden JM, Watterson J, Longee DC, Moertel CL, Dunn ME, Kurtzberg J, Scheithauer BW: Central nervous system atypical teratoid/rhabdoid tumor: Response to intensive therapy and review of the literature. J Neurooncol 1998;40:265–275.
5.
Howlett DC, King AP, Jarosz JM, Stewart RA, al-Sarraj ST, Bingham JB, Cox TC: Imaging and pathological features of primary malignant rhabdoid tumours of the brain and spine. Neuroradiology 1997;39:719–723.
6.
Oka H, Scheithauer BW: Clinicopathological characteristics of atypical teratoid/rhabdoid tumor. Neurol Med Chir (Tokyo) 1999;39:510–518.
7.
Rorke LB, Packer RJ, Biegel JA: Central nervous system atypical teratoid/rhabdoid tumor of infancy and childhood: Definition of an entity. J Neurosurg 1996;85:56–65.
8.
Rosemberg S, Menezes Y, Sousa MR, Plese P, Ciquini O: Primary malignant rhabdoid tumor of the spinal dura. Clin Neuropathol 1994;13:221–224.
9.
Deme S, Ang LC, Skaf G, Rowed DW: Primary intramedullary primitive neuroectodermal tumor of the spinal cord: Case report and review of the literature. Neurosurgery 1997;41:1417–1420.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.